Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2025-12-24 @ 2:24 PM
NCT ID:
NCT01905059
Eligibility Criteria:
Inclusion Criteria:
* HIV infection on second line treatment in the 2lady trial for at least 48 weeks
* VL ≤ 200 copies/ml since at least 6 months
* No change in ART in the last 3 months previous to the study
* CD4\> 100 cells/ml
* Signed informed consent
* Adherence \>90
Exclusion Criteria:
* Previous viral failure (at least 2 consecutive HIV RNA \>1000 copies/ml) while receiving a PI
* Ongoing pregnancy and breast feeding women
* HBsAg positive patients
* opportunistic infection or any severe or progressive disease ongoing or treated in the 3 months before screening
* Subject who in the investigator's opinion is unable to complete the study
* History or symptoms of HIV encephalopathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01905059
Study Brief:
Protocol Section:
NCT01905059